|
|
Post by mcbone on Sept 9, 2021 15:50:53 GMT -5
I don't think that's correct. MNKD was failing again soon after the 2017 Wainwright pump/dump. The Christmas massacre was a few months later. You may also recall the hit articles during the summer of 2018 calling for imminent bankruptcy. Then the UTHR deal emerged @ Sept of 2018. It's just my opinion, but Martine "saved the company."
What a load of fertilizer. Dr. Rothblatt is a shrewd attorney as well as a doctor and did not “save” Mannkind but negotiated a deal good for UTHR which of course was also good for MNKD. I’ve every confidence MNKD managmenet has been low-balled so many times it would make our heads spin, and yet they’ve never sold out. They’re holding on for a reason and you should assume that stubborness also came into play during negotations with UTHR for TreT which MNKD on their own had made an effort to test which led to the successful negotiation with UTHR. To continue to attempt to cast that work and those negotations as charity is just a bunch of foolishness. Hmmm. If MC or MNKD management on their own volition took Treprostinil and put it on the Technosphere platform, and then approached UTHR, as opposed to UTHR approaching MNKD first, that would be impressive and would show some creativity on the part of management. Is that what you're saying? Do you have evidence of that? If so, it would change my outlook on the current management. I am just a retail investor and assume that most of what I read on here is speculation, including a lot of what I write.
As to the license negotiations, they are usually confidential, during the time of the negotiations and after the license is inked. There's typically a confidentiality provision in the license. Even the ability for MC to refer to the royalty rate as "low double digits" was probably negotiated and is likely the limit of what he can reveal. So I am wondering why I "should assume that stubborness [sic] also came into play during the negotations [sic]" as opposed to assuming that the deal landed on MC's lap. Do you have some inside knowledge of the negotiations or was there something published about them as they unfolded? Again, if so, it could change my opinion and would certainly be interesting to learn.
I qualified what I wrote by saying "it's just my opinion." If you have some facts to back up what you wrote, I'd be happy to reconsider. I want MNKD management to be as good as you're suggesting, as do dozens of folks on this board who, unlike me, will gladly sing Kumbaya with you.
|
|
|
|
Post by cretin11 on Sept 9, 2021 16:03:21 GMT -5
Cool. Well it seem like you replied to his speculation with your own speculation. If we stick to known facts, we’d say “we have received at least one low-ball offer over the past 6 years, and may have received more, but if so we’ve not heard of them”. Is that fair? Thank you for coming around to basically what I asked of the poster who speculated on this. Also, see what mcbone just posted and appropriately stated. |
|
|
|
Post by tarheelblue004 on Sept 9, 2021 16:07:32 GMT -5
If I thought this were similar to what you said, including when you asked Peppy if she agreed that there were no low-ball offers, I wouldn’t have bothered chiming in. But it sounds like we are on the same page.
|
|
|
|
Post by longliner on Sept 9, 2021 16:09:00 GMT -5
|
|
|
|
Post by akemp3000 on Sept 9, 2021 16:09:44 GMT -5
The idea that Martine Rothblatt saved the company can only be described as wild speculation because no one except the players at the table knows what all the options and considerations were as the deal making progressed. It's not however wild speculation that the current management inherited a mountain of obstacles and has maneuvered this company where it's now a stable company with a promising pipeline and future. Everyone is certainly free to follow whatever speculation they wish.
|
|
|
|
Post by cretin11 on Sept 9, 2021 16:34:09 GMT -5
Pride cometh before the fall....   Reading is fundamental. 😆 |
|
|
|
Post by sportsrancho on Sept 9, 2021 16:38:40 GMT -5
“I’ve every confidence MNKD management has been low-balled so many times it would make our heads spin, and yet they’ve never sold out.” Have there been any reports supporting that notion? Seems we’d have heard if there were anything to that. SNY offered $5.50 when the stock was at $7.15. That was the only time Jackie Mann ever considered selling her shares. Al said no and then we partnered. Then there was Henry:-) And nobody heard what was said to SNY or Henry besides no. |
|
|
|
Post by longliner on Sept 9, 2021 16:48:23 GMT -5
“I’ve every confidence MNKD management has been low-balled so many times it would make our heads spin, and yet they’ve never sold out.” Have there been any reports supporting that notion? Seems we’d have heard if there were anything to that. SNY offered $5.50 when the stock was at $7.15. That was the only time Jackie Mann ever considered selling her shares. Al said no and then we partnered. Then there was Henry:-) And nobody heard what was said to SNY or Henry besides no. This is the first time I recall hearing of the Sanofi offer? |
|
|
|
Post by sportsrancho on Sept 9, 2021 17:08:08 GMT -5
SNY offered $5.50 when the stock was at $7.15. That was the only time Jackie Mann ever considered selling her shares. Al said no and then we partnered. Then there was Henry:-) And nobody heard what was said to SNY or Henry besides no. This is the first time I recall hearing of the Sanofi offer? It’s the first time I told you:-) |
|
|
|
Post by cretin11 on Sept 9, 2021 17:25:04 GMT -5
Thank you sports! Factual information, much appreciated.
|
|
|
|
Post by lazyb767 on Sept 9, 2021 18:01:04 GMT -5
The idea that Martine Rothblatt saved the company can only be described as wild speculation because no one except the players at the table knows what all the options and considerations were as the deal making progressed. It's not however wild speculation that the current management inherited a mountain of obstacles and has maneuvered this company where it's now a stable company with a promising pipeline and future. Everyone is certainly free to follow whatever speculation they wish. Straight up… and if 6 were 9 |
|
|
|
Post by prcgorman2 on Sept 9, 2021 21:36:05 GMT -5
I think it’s a bad assumption to assume there’ve been no offers other than the old guy claiming an offer from Chinese investors at an ASM. Maybe it’s only a few, but whatever, they had to be low ball offers and couldn’t have been serious. The management and board have a fiduciary responsibility to bring material offers to the shareholders, which, up until the last year or so was mainly retail investors. Obviously, MNKD management has engaged in M&A discussions because they’ve acquired more than one company, and they should be active in this area. My understanding from friends in legal and corporate finance roles is all companies of any useful market cap are constantly on the lookout for business development opportunities.
As for MNKD stalking UTHR on TreT, yes, that is exactly what I think because that’s what pipeline development companies do. They’re not just randomly trying formulations, and it is not a good assumption they plan to build sales and marketing arms for pipeline candidates. And this kind of activity is not limited to drug development companies. Many companies develop competitive products and services with every intention of accepting profitable buyouts. I’ve known the founders and CEO and CTO of 3 different companies who’ve made a career of it. If you’ve studied UTHR’s activities with Treprostinil you should have noticed they have a nuanced strategy which includes partnering, acquisition, and at least one civil suit. That defendant in the civil suit would probably agree that Dr. Rothblatt is not particularly inclined to be charitable to other companies developing competitive or potentially competitive products.
|
|
|
|
Post by uvula on Sept 10, 2021 7:19:59 GMT -5
It is interesting that once a thread goes off topic, it stays focused on the new topic.
Things are looking good but you all still find things to argue about.
|
|
|
|
Post by casualinvestor on Sept 10, 2021 9:40:10 GMT -5
The idea that Martine Rothblatt saved the company can only be described as wild speculation because no one except the players at the table knows what all the options and considerations were as the deal making progressed. It's not however wild speculation that the current management inherited a mountain of obstacles and has maneuvered this company where it's now a stable company with a promising pipeline and future. Everyone is certainly free to follow whatever speculation they wish. How about we make it less personal, and say that the partnership with UTHR saved MNKD from more dilutive raises and another RS. Martine Rothblatt was very much involved even if she didn't do it all herself |
|
|
|
Post by awesomo on Sept 10, 2021 9:57:09 GMT -5
The partnership with UTHR gave MannKind much needed up front cash and milestone payments. It also gave a legitimate endorsement for the platform moving forward with a reputable company. Oh yeah, and those royalties that everyone is projecting to come in nicely. If these were not in place, MannKind would be hemorrhaging money with completely stagnant Afrezza sales and like casualinvestor said, management would just be in a perpetual cycle of trying to raise funds at crappy rates.
Management's ability to restructure the financials leaned heavily on the prospects stemming from the partnership as well.
So we can absolutely say the partnership saved investors from being gutted into the ground.
|
|
